Stock ALNEV NEOVACS
Add to a list
To use this feature you must be a member
Log inSign up

Highlights NEOVACS

Equities

ALNEV

FR001400MV37

Market Closed - Euronext Paris
Other stock markets
 11:35:00 2024-05-29 EDT 		5-day change 1st Jan Change
0.1706 EUR -16.45% Intraday chart for NEOVACS -5.27% -91.47%
05-29 Neovacs: mRNA approach validated in preclinical trial CF
05-27 Neovacs: collaboration contract with INSERM team CF

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neovacs: mRNA approach validated in preclinical trial
CF
Neovacs: collaboration contract with INSERM team
CF
Neovacs S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Reverse Split: 1 of 10000
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALNEV Stock
  4. News NEOVACS
  5. Highlights